Queen Elizabeth University Hospital

Glasgow, Scotland G514TF

1 studies enrolling now · 11 studies all time

What they study most

Acute Ischemic Stroke, Contrast Enhancement in Magnetic Resonance Imaging, Dementia With Lewy Bodies, Dilated Cardiomyopathy, Heart Failure, Heart Failure With Reduced Ejection Fraction, Hypertension, Migraine, Multiple System Atrophy, Non-central Nervous System Pathology, Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia, Small Bowel Crohn's Disease

Studies at this site

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction — Recruiting now
Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension — Running, not enrolling
Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications — Completed
A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) — Running, not enrolling
A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems) — Completed
Study of ATH434 in Participants with Multiple System Atrophy — Completed
v4 Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-491 — Completed
Study To Evaluate the Efficacy, Safety and Tolerability of E2027 (Hereinafter Referred to as Irsenontrine) in Participants With Dementia With Lewy Bodies — Completed
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks — Completed
Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD) — Completed
Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke — Completed